Centric Wealth Management’s AbbVie ABBV Stock Holding History

Centric Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,300	Closed	-$308K	–	154
2021 Q4	$308K	Hold	2,300	–	–	0.1%	121
2021 Q3	$13K	Sell	2,300 -900	-28%	-$103K	﹤0.01%	151
2021 Q2	$19K	Hold	3,200	–	–	0.01%	147
2021 Q1	$19K	Buy	3,200 +2,000	+167%	+$214K	0.01%	210
2020 Q4	$5K	Buy	+1,200	New	+$115K	﹤0.01%	206

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Centric Wealth Management's ABBV Position: Q2 2026 in Review

Centric Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 27,968 shares worth $5.82M. The position accounts for 0.91% of the portfolio, ranked #28.

Centric Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.35M in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Centric Wealth Management held 27,968 shares of AbbVie worth $5.82M as of Q2 2026.
Centric Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.91% of Centric Wealth Management's portfolio in Q2 2026, its #28 holding.
Centric Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
Centric Wealth Management's AbbVie position peaked at $6.35M in Q4 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Centric Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.